Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Revolution_Medicines
|
| gptkbp:acquisitionYear |
2023
|
| gptkbp:CEO |
gptkb:Melanie_Nallicheri
|
| gptkbp:focusesOn |
pharmaceutical innovation
affordable medicines |
| gptkbp:foundedIn |
2020
|
| gptkbp:founder |
gptkb:Alexis_Borisy
gptkb:Melanie_Nallicheri |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
EQRx
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:status |
acquired
|
| gptkbp:website |
https://www.eqrx.com/
|
| gptkbp:bfsParent |
gptkb:Alexis_Borisy
gptkb:Arch_Venture_Partners |
| gptkbp:bfsLayer |
6
|